Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × Ipilimumab × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 27 Carcinoma, Renal Cell 16 Carcinoma, Non-Small-Cell Lung 13 Carcinoma, Hepatocellular 7 Skin Neoplasms 6 Brain Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Colorectal Neoplasms 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Neoplasms 3 Multiple Myeloma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Glioblastoma 3 Carcinoma, Transitional Cell 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Mycosis Fungoides 2 Mesothelioma, Malignant 2 Mesothelioma 2 Lymphoma, T-Cell 2

Interventions

Capecitabine 25 Oxaliplatin 23 Radiotherapy 16 Fluorouracil 15 Surgical Procedures, Operative 11 Drug Therapy 10 Chemoradiotherapy 9 Bevacizumab 9 Leucovorin 8 Consolidation Chemotherapy 7 Radiation 6 sintilimab 5 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 spartalizumab 4 Radiotherapy, Intensity-Modulated 4 Neoadjuvant Therapy 4 Cetuximab 4 trifluridine tipiracil drug combination 3 pembrolizumab 3 irinotecan sucrosofate 3 fludarabine 3 dehydroftorafur 3 Proctectomy 3 Nivolumab 3 Mastectomy, Segmental 3 Magnetic Resonance Spectroscopy 3 Endoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05732389 2025-08-07

RESET-R

Odense University Hospital

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡